Cargando…

Small-volume in vitro lipid digestion measurements for assessing drug dissolution in lipid-based formulations using SAXS

Lipid-based formulations improve the absorption capacity of poorly-water-soluble drugs and digestion of the formulation is a critical step in that absorption process. A recent approach to understanding the propensity for drug to dissolve in digesting lipid-based formulations couples an in vitro pH-s...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, Nafia F., Salim, Malinda, Binte Abu Bakar, Syaza Y., Ristroph, Kurt, Prud'homme, Robert K., Hawley, Adrian, Boyd, Ben J., Clulow, Andrew J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8881665/
https://www.ncbi.nlm.nih.gov/pubmed/35243327
http://dx.doi.org/10.1016/j.ijpx.2022.100113
_version_ 1784659524565598208
author Khan, Nafia F.
Salim, Malinda
Binte Abu Bakar, Syaza Y.
Ristroph, Kurt
Prud'homme, Robert K.
Hawley, Adrian
Boyd, Ben J.
Clulow, Andrew J.
author_facet Khan, Nafia F.
Salim, Malinda
Binte Abu Bakar, Syaza Y.
Ristroph, Kurt
Prud'homme, Robert K.
Hawley, Adrian
Boyd, Ben J.
Clulow, Andrew J.
author_sort Khan, Nafia F.
collection PubMed
description Lipid-based formulations improve the absorption capacity of poorly-water-soluble drugs and digestion of the formulation is a critical step in that absorption process. A recent approach to understanding the propensity for drug to dissolve in digesting lipid-based formulations couples an in vitro pH-stat lipolysis model to small-angle X-ray scattering (SAXS) by means of a flow-through capillary. However, the conventional pH-stat apparatus used to measure the extent of lipid digestion during such experiments requires digest volumes of 15–30 mL and drug doses of 50–200 mg, which is problematic for scarce compounds and can require excessive amounts of formulation reagents. This manuscript describes an approach to reduce the amount of material required for in vitro lipolysis experiments coupled to SAXS, for use in instances where the amount of drug or formulation medium is limited. Importantly, this was achieved while maintaining the pH stat conditions, which is critical for maintaining biorelevance and driving digestion to completion. The digestibility of infant formula with the poorly-water-soluble drugs halofantrine and clofazimine dispersed into it was measured as an exemplar paediatric-friendly lipid formulation. Halofantrine was incorporated in its powdered free base form and clofazimine was incorporated both as unformulated drug powder and as drug in nanoparticulate form prepared using Flash NanoPrecipitation. The fraction of triglyceride digested was found to be independent of vessel size and the incorporation of drug. The dissolution of the two forms of clofazimine during the digestion of infant formula were then measured using synchrotron SAXS, which revealed complete and partial solubilisation over 30 min of digestion for the powdered drug and nanoparticle formulations, respectively. The main challenge in reducing the volume of the measurements was in ensuring that thorough mixing was occurring in the smaller digestion vessel to provide uniform sampling of the dispersion medium.
format Online
Article
Text
id pubmed-8881665
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-88816652022-03-02 Small-volume in vitro lipid digestion measurements for assessing drug dissolution in lipid-based formulations using SAXS Khan, Nafia F. Salim, Malinda Binte Abu Bakar, Syaza Y. Ristroph, Kurt Prud'homme, Robert K. Hawley, Adrian Boyd, Ben J. Clulow, Andrew J. Int J Pharm X Research Paper Lipid-based formulations improve the absorption capacity of poorly-water-soluble drugs and digestion of the formulation is a critical step in that absorption process. A recent approach to understanding the propensity for drug to dissolve in digesting lipid-based formulations couples an in vitro pH-stat lipolysis model to small-angle X-ray scattering (SAXS) by means of a flow-through capillary. However, the conventional pH-stat apparatus used to measure the extent of lipid digestion during such experiments requires digest volumes of 15–30 mL and drug doses of 50–200 mg, which is problematic for scarce compounds and can require excessive amounts of formulation reagents. This manuscript describes an approach to reduce the amount of material required for in vitro lipolysis experiments coupled to SAXS, for use in instances where the amount of drug or formulation medium is limited. Importantly, this was achieved while maintaining the pH stat conditions, which is critical for maintaining biorelevance and driving digestion to completion. The digestibility of infant formula with the poorly-water-soluble drugs halofantrine and clofazimine dispersed into it was measured as an exemplar paediatric-friendly lipid formulation. Halofantrine was incorporated in its powdered free base form and clofazimine was incorporated both as unformulated drug powder and as drug in nanoparticulate form prepared using Flash NanoPrecipitation. The fraction of triglyceride digested was found to be independent of vessel size and the incorporation of drug. The dissolution of the two forms of clofazimine during the digestion of infant formula were then measured using synchrotron SAXS, which revealed complete and partial solubilisation over 30 min of digestion for the powdered drug and nanoparticle formulations, respectively. The main challenge in reducing the volume of the measurements was in ensuring that thorough mixing was occurring in the smaller digestion vessel to provide uniform sampling of the dispersion medium. Elsevier 2022-02-09 /pmc/articles/PMC8881665/ /pubmed/35243327 http://dx.doi.org/10.1016/j.ijpx.2022.100113 Text en © 2022 The Authors https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Research Paper
Khan, Nafia F.
Salim, Malinda
Binte Abu Bakar, Syaza Y.
Ristroph, Kurt
Prud'homme, Robert K.
Hawley, Adrian
Boyd, Ben J.
Clulow, Andrew J.
Small-volume in vitro lipid digestion measurements for assessing drug dissolution in lipid-based formulations using SAXS
title Small-volume in vitro lipid digestion measurements for assessing drug dissolution in lipid-based formulations using SAXS
title_full Small-volume in vitro lipid digestion measurements for assessing drug dissolution in lipid-based formulations using SAXS
title_fullStr Small-volume in vitro lipid digestion measurements for assessing drug dissolution in lipid-based formulations using SAXS
title_full_unstemmed Small-volume in vitro lipid digestion measurements for assessing drug dissolution in lipid-based formulations using SAXS
title_short Small-volume in vitro lipid digestion measurements for assessing drug dissolution in lipid-based formulations using SAXS
title_sort small-volume in vitro lipid digestion measurements for assessing drug dissolution in lipid-based formulations using saxs
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8881665/
https://www.ncbi.nlm.nih.gov/pubmed/35243327
http://dx.doi.org/10.1016/j.ijpx.2022.100113
work_keys_str_mv AT khannafiaf smallvolumeinvitrolipiddigestionmeasurementsforassessingdrugdissolutioninlipidbasedformulationsusingsaxs
AT salimmalinda smallvolumeinvitrolipiddigestionmeasurementsforassessingdrugdissolutioninlipidbasedformulationsusingsaxs
AT binteabubakarsyazay smallvolumeinvitrolipiddigestionmeasurementsforassessingdrugdissolutioninlipidbasedformulationsusingsaxs
AT ristrophkurt smallvolumeinvitrolipiddigestionmeasurementsforassessingdrugdissolutioninlipidbasedformulationsusingsaxs
AT prudhommerobertk smallvolumeinvitrolipiddigestionmeasurementsforassessingdrugdissolutioninlipidbasedformulationsusingsaxs
AT hawleyadrian smallvolumeinvitrolipiddigestionmeasurementsforassessingdrugdissolutioninlipidbasedformulationsusingsaxs
AT boydbenj smallvolumeinvitrolipiddigestionmeasurementsforassessingdrugdissolutioninlipidbasedformulationsusingsaxs
AT clulowandrewj smallvolumeinvitrolipiddigestionmeasurementsforassessingdrugdissolutioninlipidbasedformulationsusingsaxs